TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CRBU

Caribou Biosciences Inc

Healthcare · Biotechnology

1.20$ -0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CRBU
Line item 2019 2020 2021 2022 2023 2024 2025
– +113.6% -22.4% +44.3% +148.9% -71.0% +11.7%
– +45.7% -97.1% +270.0% -3.2% +11.4% -7.2%
– -481.2% – +18.5% +203.2% -80.4% +23.9%
– +45.7% +51.8% +57.4% +36.3% +16.1% -15.9%
– -14.6% +73.0% +56.3% +1.2% +20.8% -18.4%
– -64.9% +437.6% +54.3% +26.1% +17.5% -16.8%
– – – – – – –
– +400.0% -60.0% +106,612.5% – – –
– – – – – – –
– – – -78.2% +175.7% -104.7% –
– – – – – – –
– – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?